146 related articles for article (PubMed ID: 19593208)
41. The renin-aldosterone axis in kidney transplant recipients and its association with allograft function and structure.
Issa N; Ortiz F; Reule SA; Kukla A; Kasiske BL; Mauer M; Jackson S; Matas AJ; Ibrahim HN; Najafian B
Kidney Int; 2014 Feb; 85(2):404-15. PubMed ID: 23965522
[TBL] [Abstract][Full Text] [Related]
42. CYP2C9 genetic variants and losartan oxidation in a Turkish population.
Babaoglu MO; Yasar U; Sandberg M; Eliasson E; Dahl ML; Kayaalp SO; Bozkurt A
Eur J Clin Pharmacol; 2004 Jul; 60(5):337-42. PubMed ID: 15197523
[TBL] [Abstract][Full Text] [Related]
43. Hemodynamic and renal effects of indomethacin in losartan-treated hypertensive individuals.
Olsen ME; Thomsen T; Hassager C; Ibsen H; Dige-Petersen H
Am J Hypertens; 1999 Feb; 12(2 Pt 1):209-16. PubMed ID: 10090350
[TBL] [Abstract][Full Text] [Related]
44.
Sinitsina II; Boyarko AV; Temirbulatov II; Sychev DA; Akmalova KA; Sozaeva ZA; Grishina EA; Mirzaev KB; Asoskova AV; Fisenko VP
Drug Metab Pers Ther; 2023 Jun; 38(2):163-168. PubMed ID: 36580432
[TBL] [Abstract][Full Text] [Related]
45. Pharmacoepigenetics of hypertension: genome-wide methylation analysis of responsiveness to four classes of antihypertensive drugs using a double-blind crossover study design.
Nuotio ML; Sánez Tähtisalo H; Lahtinen A; Donner K; Fyhrquist F; Perola M; Kontula KK; Hiltunen TP
Epigenetics; 2022 Nov; 17(11):1432-1445. PubMed ID: 35213289
[TBL] [Abstract][Full Text] [Related]
46. [Comparative effects of losartan and amlodipine on activities of sympathetic nerve, renin-angiotensin-aldosterone system and brain natriuretic peptide in the elderly hypertensive patients].
Tsutamoto T; Maeda K; Mabuchi N; Tsutsui T; Ohnishi M; Kinoshita M
Nihon Ronen Igakkai Zasshi; 2002 May; 39(3):303-7. PubMed ID: 12073593
[TBL] [Abstract][Full Text] [Related]
47. Genetic polymorphisms related to the renin-angiotensin-aldosterone system and response to antihypertensive drugs.
Taverne K; de Groot M; de Boer A; Klungel O
Expert Opin Drug Metab Toxicol; 2010 Apr; 6(4):439-60. PubMed ID: 20102285
[TBL] [Abstract][Full Text] [Related]
48. Pharmacokinetics and blood pressure response of losartan in end-stage renal disease.
Sica DA; Halstenson CE; Gehr TW; Keane WF
Clin Pharmacokinet; 2000 Jun; 38(6):519-26. PubMed ID: 10885588
[TBL] [Abstract][Full Text] [Related]
49. Diagnosis and treatment of low-renin hypertension.
Mulatero P; Verhovez A; Morello F; Veglio F
Clin Endocrinol (Oxf); 2007 Sep; 67(3):324-34. PubMed ID: 17573898
[TBL] [Abstract][Full Text] [Related]
50. Aldosterone stimulation by angiotensin II : influence of gender, plasma renin, and familial resemblance.
Giacché M; Vuagnat A; Hunt SC; Hopkins PN; Fisher ND; Azizi M; Corvol P; Williams GH; Jeunemaitre X
Hypertension; 2000 Mar; 35(3):710-6. PubMed ID: 10720583
[TBL] [Abstract][Full Text] [Related]
51. Frequency of CYP2C9 alleles in Koreans and their effects on losartan pharmacokinetics.
Bae JW; Choi CI; Kim MJ; Oh DH; Keum SK; Park JI; Kim BH; Bang HK; Oh SG; Kang BS; Park HJ; Kim HD; Ha JH; Shin HJ; Kim YH; Na HS; Chung MW; Jang CG; Lee SY
Acta Pharmacol Sin; 2011 Oct; 32(10):1303-8. PubMed ID: 21841812
[TBL] [Abstract][Full Text] [Related]
52. CYP2C9-mediated metabolic activation of losartan detected by a highly sensitive cell-based screening assay.
Iwamura A; Fukami T; Hosomi H; Nakajima M; Yokoi T
Drug Metab Dispos; 2011 May; 39(5):838-46. PubMed ID: 21321060
[TBL] [Abstract][Full Text] [Related]
53. Effects of losartan and amlodipine on intrarenal hemodynamics and TGF-beta(1) plasma levels in a crossover trial in renal transplant recipients.
Iñigo P; Campistol JM; Lario S; Piera C; Campos B; Bescós M; Oppenheimer F; Rivera F
J Am Soc Nephrol; 2001 Apr; 12(4):822-827. PubMed ID: 11274244
[TBL] [Abstract][Full Text] [Related]
54. Lys(173)Arg and -344T/C variants of CYP11B2 in Japanese patients with low-renin hypertension.
Komiya I; Yamada T; Takara M; Asawa T; Shimabukuro M; Nishimori T; Takasu N
Hypertension; 2000 Mar; 35(3):699-703. PubMed ID: 10720581
[TBL] [Abstract][Full Text] [Related]
55. Effect of the single CYP2C9*3 allele on pharmacokinetics and pharmacodynamics of losartan in healthy Japanese subjects.
Sekino K; Kubota T; Okada Y; Yamada Y; Yamamoto K; Horiuchi R; Kimura K; Iga T
Eur J Clin Pharmacol; 2003 Nov; 59(8-9):589-92. PubMed ID: 14504849
[TBL] [Abstract][Full Text] [Related]
56. Aldosterone response to antihypertensive treatment.
de Leeuw PW; van Soest GA; Birkenhäger WH
Clin Exp Hypertens A; 1982; 4(9-10):1913-21. PubMed ID: 6291819
[TBL] [Abstract][Full Text] [Related]
57. Renal BOLD-MRI relates to kidney function and activity of the renin-angiotensin-aldosterone system in hypertensive patients.
Vink EE; de Boer A; Hoogduin HJ; Voskuil M; Leiner T; Bots ML; Joles JA; Blankestijn PJ
J Hypertens; 2015 Mar; 33(3):597-603; discussion 603-4. PubMed ID: 25479032
[TBL] [Abstract][Full Text] [Related]
58. Time-dependent effects of low-dose aspirin on plasma renin activity, aldosterone, cortisol, and catecholamines.
Snoep JD; Hovens MM; Pasha SM; Frölich M; Pijl H; Tamsma JT; Huisman MV
Hypertension; 2009 Nov; 54(5):1136-42. PubMed ID: 19805643
[TBL] [Abstract][Full Text] [Related]
59. One-year renal and cardiac effects of bisoprolol versus losartan in recently diagnosed hypertensive patients: a randomized, double-blind study.
Parrinello G; Paterna S; Torres D; Di Pasquale P; Mezzero M; La Rocca G; Cardillo M; Trapanese C; Caradonna M; Licata G
Clin Drug Investig; 2009; 29(9):591-600. PubMed ID: 19663521
[TBL] [Abstract][Full Text] [Related]
60. Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan.
Vogt L; Waanders F; Boomsma F; de Zeeuw D; Navis G
J Am Soc Nephrol; 2008 May; 19(5):999-1007. PubMed ID: 18272844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
